Respiratory Exchange Clevleand Clinic Respiratory Institute

Military burn pits were used during deployment to burn away any kind of waste created. The fumes produced have caused serious lung injury and disease. Drs. Mauve MacMurdo and Neha Solanki discuss burn pit exposure, legislation designed to help military who have developed deployment-related lung disease, and the need to evaluate and support these patients.

Dr. Peter Mazzone talks with Drs. Sethi Sonali and Angel Coz about some of the highlights from the CHEST 2022 conference, including the two-part Critical Care Year End Review covering mechanical ventilation, neurology, ICU, sepsis, ARDIS and surgical critical care.

Dr. Humberto Choi, director of Cleveland Clinic’s Smoking Cessation Program, discusses ways for clinicians to be proactive and individualize treatment options to help people quit smoking. He also reviews electronic cigarettes, vaping and why they aren’t a safer alternative to smoking tobacco.

Dr. Elliot Dasenbrook, founder and director of the Cleveland Clinic Adult Cystic Fibrosis Program, discusses the formation of the multidisciplinary adult program. He covers past treatments and how the new modulators have made such a dramatic difference for patient care, including patients on the lung transplant waiting list. Dr. Dasenbrook also talks about how the need for transitional care, from pediatric to adult care, of the CF patient has become an imperative particularly as CF patients now live well into adulthood.

Liver disease presents a high burden, both on the society as well as healthcare system. Dr. Aanchal Kapoor, founder and director of the Medical Intensive Liver Unit (MILU), talks about the creation of this ICU Critical Care unit completely dedicated to the care of patients with severe liver disease. Dr. Kapoor discusses how this multidisciplinary unit works with staff from multiple areas including transplant hepatology, liver transplant surgery, physical therapy, dieticians, social workers, transplant coordinators and hepatology.

Dr. Daniel Culver, chairman of the Pulmonary Department in the Respiratory Institute at Cleveland Clinic, dives in to the topic of interstitial lung diseases, their diagnosis and management. He covers use of transbronchial cryobiopsy, the benefits of multidisciplinary discussion, and changes in the use of immunosuppressive and anti-fibrotic therapies. Dr. Culver talks about the need for identifying and taking care of comorbidities as a critical part of managing care of these patients, and offers some considerations on the future of diagnosis and therapies.